Drawing for PANOPTES

USPTO serial 88166477

PANOPTES

Reviewed by CopyMark Law Group

Reg. 5818496Status 710
Filing date
Status date
Registration date
Jul 30, 2019
Examiner
SETTLES LEWIS, SHAILA E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with PANOPTES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael Fedrick

MICHAEL FEDRICK LOZA & LOZA, LLP305 N. SECOND AVE. #127UPLAND, CA 91786-6064UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for industrial and scientific purposes, namely, chemical compounds for use in the pharmaceutical industrySECTION 8 - CANCELLED—
005Pharmaceutical and veterinary preparations for the treatment of inflammatory and chronic eye diseasesSECTION 8 - CANCELLED—
042Scientific and technological services and research related to the treatment of inflammatory and chronic eye diseases, namely, scientific research, pharmaceutical research and development, pharmaceutical testing, analysis, and evaluation, and industrial research related to the treatment of inflammatory and chronic eye diseases; research and development of small molecule based therapies for the treatment of eye diseasesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 13, 2026C8..CANCELLED SEC. 8 (6-YR)—
Jul 30, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 30, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 27, 2019DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jun 27, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 20, 2019IUCNNOTICE OF ALLOWANCE CANCELLED—
Jun 20, 2019EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
May 14, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 27, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 2, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 30, 2019DOCKASSIGNED TO EXAMINER—
Nov 5, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 26, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance